| 1.7 |
5.2 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 1.1 |
4.3 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) positive regulation of connective tissue replacement(GO:1905205) |
| 0.9 |
2.7 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.7 |
2.2 |
GO:0097198 |
histone H3-K36 trimethylation(GO:0097198) |
| 0.7 |
1.4 |
GO:1990164 |
histone H2A phosphorylation(GO:1990164) |
| 0.7 |
2.0 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.6 |
1.8 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.6 |
1.7 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.5 |
5.2 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.5 |
2.6 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.5 |
2.0 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.5 |
3.3 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.5 |
1.4 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.5 |
1.4 |
GO:0044830 |
modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.5 |
1.4 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.4 |
4.4 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.4 |
1.7 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.4 |
2.6 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.4 |
1.7 |
GO:0021896 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.4 |
2.1 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.4 |
1.6 |
GO:1900248 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.4 |
1.5 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 |
1.1 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.4 |
3.7 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.4 |
1.1 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.4 |
5.1 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.4 |
1.5 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.4 |
1.1 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.4 |
2.2 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.4 |
1.1 |
GO:0031585 |
regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
| 0.4 |
1.1 |
GO:1903515 |
calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.4 |
1.8 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.4 |
0.7 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.3 |
3.4 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.3 |
1.7 |
GO:2001038 |
regulation of cellular response to drug(GO:2001038) |
| 0.3 |
1.3 |
GO:2000230 |
negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.3 |
1.0 |
GO:1900276 |
regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.3 |
1.0 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.3 |
1.0 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.3 |
1.0 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.3 |
1.0 |
GO:0035750 |
protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.3 |
1.9 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.3 |
0.6 |
GO:0032898 |
neurotrophin production(GO:0032898) regulation of neurotrophin production(GO:0032899) negative regulation of neurotrophin production(GO:0032900) |
| 0.3 |
3.4 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.3 |
2.8 |
GO:0043634 |
polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.3 |
0.3 |
GO:0034694 |
response to prostaglandin(GO:0034694) |
| 0.3 |
0.9 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.3 |
0.6 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.3 |
4.3 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.3 |
0.3 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.3 |
0.9 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.3 |
0.6 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.3 |
0.8 |
GO:1904395 |
positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.3 |
1.1 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.3 |
0.8 |
GO:0021718 |
superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.3 |
0.8 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.3 |
0.8 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.3 |
0.5 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.3 |
1.0 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.3 |
2.6 |
GO:0033183 |
negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.3 |
0.5 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.3 |
1.0 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.3 |
1.0 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.3 |
1.3 |
GO:1901908 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.3 |
1.3 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.2 |
1.2 |
GO:0071874 |
cellular response to norepinephrine stimulus(GO:0071874) |
| 0.2 |
1.0 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.2 |
0.7 |
GO:0033319 |
UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.2 |
0.2 |
GO:0051495 |
positive regulation of cytoskeleton organization(GO:0051495) |
| 0.2 |
1.9 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.2 |
1.4 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.2 |
0.9 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.2 |
0.9 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.2 |
2.1 |
GO:0090230 |
regulation of centromere complex assembly(GO:0090230) |
| 0.2 |
0.9 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.2 |
0.7 |
GO:0060648 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) mammary gland bud morphogenesis(GO:0060648) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 0.2 |
1.2 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.2 |
1.2 |
GO:1905075 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.2 |
2.6 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.2 |
1.2 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.2 |
1.6 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.2 |
0.7 |
GO:1901340 |
negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.2 |
3.2 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.2 |
3.2 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
0.7 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.2 |
2.7 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.2 |
0.7 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.2 |
1.8 |
GO:0006499 |
N-terminal protein myristoylation(GO:0006499) |
| 0.2 |
2.4 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
1.5 |
GO:1903788 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.2 |
2.4 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.2 |
1.1 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 |
1.3 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.2 |
0.4 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 |
1.1 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.2 |
1.7 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.2 |
0.6 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.2 |
2.5 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 |
0.2 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.2 |
0.6 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.2 |
0.6 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 |
0.6 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.2 |
1.6 |
GO:0051549 |
positive regulation of keratinocyte migration(GO:0051549) |
| 0.2 |
0.6 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.2 |
0.2 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 |
0.4 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.2 |
0.2 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.2 |
0.4 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.2 |
0.8 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.2 |
0.6 |
GO:0060734 |
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.2 |
1.3 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.2 |
0.4 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 |
0.4 |
GO:1903307 |
positive regulation of regulated secretory pathway(GO:1903307) |
| 0.2 |
0.4 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.2 |
0.6 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.2 |
2.6 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.2 |
0.7 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 |
0.5 |
GO:1901222 |
regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.2 |
0.5 |
GO:1901355 |
response to rapamycin(GO:1901355) response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.2 |
1.6 |
GO:0014916 |
regulation of lung blood pressure(GO:0014916) |
| 0.2 |
1.2 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.2 |
3.8 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.2 |
2.1 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.2 |
0.7 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.2 |
0.7 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.2 |
1.0 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 |
0.5 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.2 |
3.7 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.2 |
1.2 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.2 |
0.8 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.2 |
3.0 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.2 |
1.2 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 |
0.7 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 |
1.3 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.2 |
0.7 |
GO:0032446 |
protein modification by small protein conjugation(GO:0032446) |
| 0.2 |
0.5 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.2 |
0.3 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.2 |
0.2 |
GO:0036003 |
positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
| 0.2 |
3.1 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.2 |
0.5 |
GO:1990258 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.2 |
1.0 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 |
1.0 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 |
1.0 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.2 |
1.0 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.2 |
1.3 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.2 |
0.6 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.2 |
1.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.2 |
0.5 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.2 |
0.3 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.2 |
0.6 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.2 |
0.5 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 0.2 |
1.5 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.2 |
1.4 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
1.5 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.2 |
0.8 |
GO:0021683 |
cerebellar granular layer morphogenesis(GO:0021683) |
| 0.2 |
0.5 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.2 |
0.6 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.2 |
0.8 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 |
0.4 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 |
1.2 |
GO:0010626 |
regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 |
1.0 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 |
1.0 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
2.0 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.4 |
GO:0051780 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.1 |
2.2 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.1 |
3.0 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 |
4.4 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.1 |
0.3 |
GO:0071504 |
cellular response to heparin(GO:0071504) |
| 0.1 |
0.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.1 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
0.4 |
GO:0034402 |
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.1 |
0.4 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
| 0.1 |
0.3 |
GO:0002424 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 0.1 |
0.4 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 |
1.1 |
GO:1901297 |
positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.1 |
0.8 |
GO:0071386 |
cellular response to corticosterone stimulus(GO:0071386) |
| 0.1 |
0.3 |
GO:0035523 |
protein K29-linked deubiquitination(GO:0035523) |
| 0.1 |
0.1 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.1 |
0.7 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
0.9 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.1 |
0.8 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
0.4 |
GO:1903911 |
positive regulation of receptor clustering(GO:1903911) |
| 0.1 |
0.7 |
GO:2000639 |
regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.1 |
1.3 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
0.4 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.1 |
0.9 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.1 |
0.5 |
GO:0048372 |
lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 0.1 |
0.4 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.1 |
0.7 |
GO:0008050 |
courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
| 0.1 |
0.8 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.1 |
0.5 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
1.4 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.1 |
0.4 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
1.3 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 |
0.8 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.6 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 |
1.1 |
GO:1902748 |
melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.1 |
1.0 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.4 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.1 |
1.0 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
1.1 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.1 |
0.7 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
1.0 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
2.6 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.1 |
0.4 |
GO:0010628 |
positive regulation of gene expression(GO:0010628) |
| 0.1 |
0.5 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
0.4 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.1 |
0.2 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.7 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.1 |
0.9 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.1 |
0.4 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
1.0 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.7 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
0.4 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.1 |
0.1 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 0.1 |
0.2 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 |
0.1 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.1 |
0.2 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.1 |
1.8 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.1 |
0.2 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.4 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.1 |
0.4 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 |
0.2 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
5.2 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 |
0.3 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
0.7 |
GO:0035933 |
glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
| 0.1 |
0.8 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.3 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.6 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
2.3 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.1 |
0.3 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
0.6 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.1 |
0.1 |
GO:1904815 |
negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.1 |
0.3 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.1 |
0.6 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.1 |
0.6 |
GO:1902019 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 |
0.1 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.1 |
2.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
1.1 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 |
0.3 |
GO:0015993 |
L-ascorbic acid transport(GO:0015882) molecular hydrogen transport(GO:0015993) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
1.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.2 |
GO:0032304 |
negative regulation of icosanoid secretion(GO:0032304) negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.1 |
0.2 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
0.3 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.1 |
0.4 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 0.1 |
0.4 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.1 |
0.2 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 |
0.2 |
GO:0042633 |
molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.1 |
0.3 |
GO:0050894 |
determination of affect(GO:0050894) |
| 0.1 |
0.4 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.1 |
0.1 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.1 |
5.1 |
GO:0071174 |
mitotic spindle checkpoint(GO:0071174) |
| 0.1 |
0.1 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.1 |
0.5 |
GO:0050768 |
negative regulation of neurogenesis(GO:0050768) |
| 0.1 |
0.3 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 |
0.7 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.1 |
0.3 |
GO:0060585 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.1 |
1.3 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
| 0.1 |
0.9 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.1 |
1.0 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 |
0.3 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
1.4 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.1 |
0.5 |
GO:1904764 |
negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.1 |
1.6 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.6 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.1 |
0.2 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.1 |
0.3 |
GO:0031952 |
regulation of protein autophosphorylation(GO:0031952) |
| 0.1 |
0.4 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 |
0.4 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.1 |
0.6 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.1 |
0.3 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 |
1.0 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 |
0.6 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.1 |
0.7 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 |
0.4 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.2 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 |
0.3 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.1 |
0.4 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.1 |
0.2 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
| 0.1 |
0.6 |
GO:0090647 |
modulation of age-related behavioral decline(GO:0090647) |
| 0.1 |
1.3 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
1.3 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.1 |
0.5 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.1 |
0.4 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.1 |
0.3 |
GO:0048867 |
ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
| 0.1 |
2.9 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.4 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.1 |
0.8 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.1 |
0.3 |
GO:0032707 |
negative regulation of interleukin-23 production(GO:0032707) |
| 0.1 |
0.5 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 |
0.7 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 |
0.3 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
0.6 |
GO:0070458 |
establishment of blood-nerve barrier(GO:0008065) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 |
0.7 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 |
0.6 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.1 |
0.9 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
1.3 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.1 |
1.4 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.1 |
0.1 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 |
0.5 |
GO:1901090 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.1 |
1.2 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.1 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
0.7 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
2.9 |
GO:0043090 |
amino acid import(GO:0043090) |
| 0.1 |
0.9 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.1 |
0.6 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.1 |
0.2 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.1 |
0.6 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.1 |
0.9 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.1 |
0.3 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.1 |
0.3 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.1 |
0.7 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.1 |
0.7 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.1 |
0.5 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.1 |
0.3 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.1 |
1.6 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
0.8 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.4 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.1 |
0.4 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.1 |
0.4 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 |
1.2 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.9 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
0.4 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 |
0.3 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.1 |
1.4 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
0.3 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.1 |
0.2 |
GO:0070613 |
regulation of protein processing(GO:0070613) |
| 0.1 |
1.8 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.1 |
0.9 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 |
0.1 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.1 |
0.3 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.1 |
0.3 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 |
0.8 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.1 |
0.3 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.1 |
1.2 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 |
0.2 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.1 |
0.5 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
1.9 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
0.4 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
0.3 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.6 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
1.2 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 |
0.6 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.1 |
0.3 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.1 |
0.2 |
GO:0035912 |
dorsal aorta morphogenesis(GO:0035912) |
| 0.1 |
1.3 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 |
0.3 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.1 |
0.4 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 |
0.3 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.1 |
0.3 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.1 |
0.7 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
1.5 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 |
1.3 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
1.4 |
GO:0098909 |
regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.1 |
0.3 |
GO:0050993 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.1 |
0.2 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.1 |
1.1 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 |
0.3 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.1 |
0.1 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.1 |
0.4 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.1 |
0.2 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.1 |
0.2 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.1 |
0.2 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 |
0.4 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.1 |
0.4 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.1 |
1.0 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 |
0.7 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.7 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.1 |
1.6 |
GO:0021696 |
cerebellar cortex morphogenesis(GO:0021696) |
| 0.1 |
3.1 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.1 |
0.5 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 |
0.9 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 |
0.3 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.1 |
0.3 |
GO:0006848 |
pyruvate transport(GO:0006848) mitochondrial pyruvate transport(GO:0006850) pyruvate transmembrane transport(GO:1901475) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.1 |
0.5 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.1 |
0.3 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
0.3 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.1 |
0.8 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 |
0.7 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
0.9 |
GO:0048016 |
inositol phosphate-mediated signaling(GO:0048016) |
| 0.1 |
0.5 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.1 |
0.2 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.1 |
0.2 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) positive regulation of necrotic cell death(GO:0010940) |
| 0.1 |
0.1 |
GO:0097252 |
oligodendrocyte apoptotic process(GO:0097252) |
| 0.1 |
2.1 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
1.1 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.1 |
0.3 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.1 |
0.2 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.1 |
0.5 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 |
0.3 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 |
0.5 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 0.1 |
0.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) maintenance of protein localization in organelle(GO:0072595) |
| 0.1 |
0.9 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 |
0.7 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
0.2 |
GO:0002071 |
glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
| 0.1 |
0.1 |
GO:0072337 |
modified amino acid transport(GO:0072337) |
| 0.1 |
0.3 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
0.2 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.1 |
2.2 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.1 |
0.3 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 |
0.1 |
GO:0014062 |
regulation of serotonin secretion(GO:0014062) |
| 0.1 |
0.1 |
GO:0034351 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 |
0.1 |
GO:1902824 |
positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.1 |
0.1 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 |
0.3 |
GO:0097069 |
response to human chorionic gonadotropin(GO:0044752) cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.1 |
0.1 |
GO:1903979 |
negative regulation of microglial cell activation(GO:1903979) |
| 0.1 |
1.1 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
1.4 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.1 |
0.5 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.1 |
GO:1990737 |
response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.1 |
0.5 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.1 |
0.2 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.1 |
0.2 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.1 |
1.3 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.7 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 |
0.8 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.2 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 |
0.1 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.1 |
0.4 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 |
0.5 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
0.7 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 |
0.3 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 |
1.1 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 |
0.7 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 |
0.4 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.1 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.1 |
0.2 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.4 |
GO:0021681 |
cerebellar granular layer development(GO:0021681) |
| 0.1 |
0.5 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
0.3 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
0.2 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.1 |
0.6 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.1 |
3.9 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.1 |
0.1 |
GO:0051307 |
meiotic chromosome separation(GO:0051307) |
| 0.1 |
0.2 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
0.1 |
GO:0007215 |
glutamate receptor signaling pathway(GO:0007215) regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.1 |
0.1 |
GO:0032097 |
positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.1 |
3.2 |
GO:1990090 |
cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 |
0.3 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 |
0.2 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.1 |
0.3 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
0.2 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.5 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 |
0.6 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.1 |
0.4 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.1 |
0.3 |
GO:1901490 |
regulation of lymphangiogenesis(GO:1901490) |
| 0.1 |
1.6 |
GO:0009301 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
3.0 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 |
0.2 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.1 |
0.1 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.1 |
1.4 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.3 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.5 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.1 |
0.3 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.1 |
0.2 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
0.9 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.1 |
0.4 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.1 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 |
0.2 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.1 |
0.2 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 |
0.1 |
GO:0035265 |
organ growth(GO:0035265) |
| 0.1 |
1.8 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.1 |
0.4 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.5 |
GO:0045779 |
negative regulation of bone resorption(GO:0045779) |
| 0.1 |
0.2 |
GO:0030856 |
regulation of epithelial cell differentiation(GO:0030856) |
| 0.1 |
0.1 |
GO:2000794 |
regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
| 0.1 |
0.5 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.1 |
0.5 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.1 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 |
0.6 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 |
1.1 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.5 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.1 |
0.1 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
0.2 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
| 0.1 |
0.2 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.6 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.1 |
1.0 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
0.3 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.6 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.4 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.3 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
| 0.1 |
0.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.3 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.1 |
0.1 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.1 |
0.3 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.1 |
0.6 |
GO:0030730 |
sequestering of triglyceride(GO:0030730) |
| 0.1 |
0.3 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
0.7 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
0.3 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
0.2 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.1 |
0.2 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.1 |
0.1 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 |
2.5 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.5 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 |
0.1 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.1 |
0.1 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.1 |
0.4 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 |
0.4 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.1 |
0.7 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.1 |
0.3 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 |
0.1 |
GO:0043132 |
NAD transport(GO:0043132) |
| 0.1 |
1.0 |
GO:0060964 |
regulation of gene silencing by miRNA(GO:0060964) |
| 0.1 |
0.9 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.7 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
0.7 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.5 |
GO:1900151 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.8 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 |
0.2 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.1 |
0.8 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.1 |
0.4 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
0.5 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.1 |
0.1 |
GO:2001190 |
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 0.1 |
1.0 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
7.1 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
0.4 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) |
| 0.1 |
0.6 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.4 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.1 |
0.5 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.2 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 |
0.1 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.1 |
1.3 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 |
0.9 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 |
1.6 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.1 |
0.2 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.1 |
0.1 |
GO:1903078 |
positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.1 |
0.1 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 |
0.2 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.1 |
0.6 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.1 |
0.7 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
0.4 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.1 |
0.2 |
GO:2001140 |
regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
| 0.1 |
0.1 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.1 |
8.3 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 |
0.3 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 |
1.3 |
GO:0006853 |
carnitine shuttle(GO:0006853) |
| 0.1 |
0.9 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.1 |
0.2 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 |
0.1 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.1 |
0.2 |
GO:0090222 |
centrosome-templated microtubule nucleation(GO:0090222) |
| 0.1 |
0.1 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.1 |
2.4 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
0.1 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.1 |
0.3 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.1 |
6.4 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 |
0.3 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.1 |
1.3 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
0.4 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.1 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 |
0.5 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.2 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.0 |
0.2 |
GO:0030705 |
cytoskeleton-dependent intracellular transport(GO:0030705) |
| 0.0 |
0.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.1 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.0 |
0.1 |
GO:0010956 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.0 |
0.8 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.0 |
0.3 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.0 |
0.1 |
GO:0046167 |
glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.0 |
0.1 |
GO:0006714 |
sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 0.0 |
0.2 |
GO:0071469 |
detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
| 0.0 |
0.4 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.0 |
0.4 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.2 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 |
0.0 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.0 |
0.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.0 |
0.2 |
GO:2001301 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.0 |
0.2 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.0 |
0.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 |
2.9 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 |
0.2 |
GO:0019050 |
suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
| 0.0 |
0.2 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 |
0.4 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.0 |
0.2 |
GO:0048385 |
regulation of retinoic acid receptor signaling pathway(GO:0048385) negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 |
0.6 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.5 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.3 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
1.2 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.0 |
0.6 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.1 |
GO:0071865 |
regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
| 0.0 |
0.3 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.0 |
0.5 |
GO:0070197 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.0 |
0.3 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.0 |
0.2 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.0 |
0.2 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.5 |
GO:0019054 |
modulation by virus of host process(GO:0019054) |
| 0.0 |
1.1 |
GO:0051983 |
regulation of chromosome segregation(GO:0051983) |
| 0.0 |
0.0 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.0 |
0.9 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 |
0.1 |
GO:0051086 |
chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.0 |
0.1 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.0 |
0.2 |
GO:1903597 |
negative regulation of gap junction assembly(GO:1903597) |
| 0.0 |
0.4 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 |
0.1 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.0 |
1.1 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 |
0.2 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.0 |
0.7 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
1.4 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.0 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.0 |
1.4 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.6 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 |
0.2 |
GO:0060282 |
regulation of oocyte development(GO:0060281) positive regulation of oocyte development(GO:0060282) |
| 0.0 |
0.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.0 |
0.5 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.1 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 |
0.4 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.0 |
0.4 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
1.2 |
GO:0045589 |
regulation of regulatory T cell differentiation(GO:0045589) |
| 0.0 |
0.1 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.0 |
0.5 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.0 |
0.2 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.0 |
0.5 |
GO:1903944 |
regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.0 |
0.2 |
GO:1900077 |
negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.0 |
0.4 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 |
0.1 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.0 |
0.4 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.3 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.2 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.1 |
GO:0043313 |
regulation of neutrophil degranulation(GO:0043313) |
| 0.0 |
0.1 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.0 |
1.3 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.5 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.0 |
0.2 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 |
0.1 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.0 |
0.0 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.0 |
0.4 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.0 |
0.2 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 0.0 |
0.3 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.6 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.5 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 |
0.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 |
0.9 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.0 |
0.2 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.4 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.2 |
GO:0045634 |
regulation of melanocyte differentiation(GO:0045634) |
| 0.0 |
0.3 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.0 |
0.1 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.0 |
0.7 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.4 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 |
1.1 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.2 |
GO:0099624 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.0 |
0.2 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 0.0 |
0.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.6 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 0.0 |
0.2 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.0 |
0.6 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 |
0.3 |
GO:0048806 |
genitalia development(GO:0048806) |
| 0.0 |
0.4 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.5 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 |
0.2 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.0 |
0.6 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.0 |
0.3 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.0 |
0.7 |
GO:0010744 |
positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
| 0.0 |
0.0 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.0 |
0.1 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.0 |
1.2 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.0 |
1.0 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.5 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.0 |
0.3 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.0 |
0.3 |
GO:0030473 |
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
| 0.0 |
1.7 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 |
2.5 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.5 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.0 |
1.2 |
GO:0043114 |
regulation of vascular permeability(GO:0043114) |
| 0.0 |
0.1 |
GO:1903573 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
| 0.0 |
0.7 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.3 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.0 |
0.1 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
| 0.0 |
0.1 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.0 |
0.1 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.0 |
0.1 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.0 |
0.3 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.0 |
0.1 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.0 |
0.1 |
GO:0010986 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.0 |
0.3 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
1.4 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.0 |
0.7 |
GO:0035358 |
regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
| 0.0 |
0.3 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.0 |
0.2 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.2 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.0 |
0.8 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 |
0.1 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.0 |
0.3 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.3 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.0 |
0.4 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.4 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.6 |
GO:0048713 |
regulation of oligodendrocyte differentiation(GO:0048713) |
| 0.0 |
0.2 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 |
0.1 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.0 |
0.2 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 |
0.1 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.0 |
0.3 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.6 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.0 |
0.3 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.0 |
0.2 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.1 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.0 |
0.2 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.0 |
0.1 |
GO:1903364 |
positive regulation of cellular protein catabolic process(GO:1903364) |
| 0.0 |
6.1 |
GO:0007173 |
epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.0 |
0.1 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 |
0.1 |
GO:1903778 |
protein localization to vacuolar membrane(GO:1903778) |
| 0.0 |
0.2 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.0 |
0.2 |
GO:0009217 |
dGTP catabolic process(GO:0006203) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
| 0.0 |
1.4 |
GO:0006688 |
glycosphingolipid biosynthetic process(GO:0006688) |
| 0.0 |
0.4 |
GO:0060307 |
regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
| 0.0 |
0.1 |
GO:0030001 |
metal ion transport(GO:0030001) |
| 0.0 |
0.3 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.0 |
0.5 |
GO:0036376 |
sodium ion export from cell(GO:0036376) |
| 0.0 |
0.3 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 |
0.3 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.0 |
0.8 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.4 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.7 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.5 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.1 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.0 |
0.2 |
GO:0006311 |
meiotic gene conversion(GO:0006311) |
| 0.0 |
0.1 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.0 |
0.2 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.0 |
0.1 |
GO:0002877 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
| 0.0 |
0.2 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 |
0.1 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.0 |
0.1 |
GO:0045841 |
negative regulation of mitotic metaphase/anaphase transition(GO:0045841) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) |
| 0.0 |
0.1 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.0 |
1.3 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
0.4 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 |
0.3 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.0 |
0.1 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.0 |
0.1 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.0 |
0.1 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.0 |
0.1 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.0 |
0.1 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.0 |
0.1 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.3 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.0 |
0.3 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.0 |
0.3 |
GO:0046959 |
habituation(GO:0046959) |
| 0.0 |
0.2 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 |
0.4 |
GO:0031034 |
myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) |
| 0.0 |
0.1 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.0 |
0.3 |
GO:2000352 |
negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.0 |
0.3 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
0.1 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 |
0.1 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.0 |
0.2 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 |
0.4 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.2 |
GO:0002692 |
negative regulation of cellular extravasation(GO:0002692) |
| 0.0 |
0.3 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 |
0.1 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 |
0.1 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.0 |
0.1 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.0 |
0.2 |
GO:0007219 |
Notch signaling pathway(GO:0007219) |
| 0.0 |
0.3 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.0 |
0.3 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 |
0.1 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.0 |
0.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.0 |
0.6 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 |
0.1 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.0 |
0.2 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
0.1 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
| 0.0 |
0.1 |
GO:1904298 |
positive regulation of neutrophil degranulation(GO:0043315) positive regulation of interleukin-6 biosynthetic process(GO:0045410) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.0 |
0.9 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.0 |
0.3 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.0 |
0.3 |
GO:0001502 |
cartilage condensation(GO:0001502) |
| 0.0 |
0.4 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.0 |
0.5 |
GO:0035094 |
response to nicotine(GO:0035094) |
| 0.0 |
2.4 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.0 |
0.1 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.0 |
0.1 |
GO:0050832 |
response to fungus(GO:0009620) defense response to fungus(GO:0050832) |
| 0.0 |
0.8 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.0 |
0.3 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.0 |
0.3 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.1 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.0 |
0.3 |
GO:0003356 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.0 |
0.1 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.0 |
0.2 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.0 |
0.4 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 |
0.1 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 |
0.0 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.6 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.8 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.0 |
0.1 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 |
0.2 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.0 |
0.1 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.0 |
0.2 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.0 |
0.2 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.4 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.2 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.0 |
0.1 |
GO:0030239 |
myofibril assembly(GO:0030239) |
| 0.0 |
0.5 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.0 |
0.2 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.0 |
0.1 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.0 |
0.2 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.2 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.0 |
0.1 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.0 |
0.2 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.1 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.0 |
0.8 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.0 |
0.8 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.0 |
0.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.0 |
0.2 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.6 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 |
0.2 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 |
0.1 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.0 |
0.1 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.0 |
0.2 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.1 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.0 |
0.1 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.0 |
0.1 |
GO:0036071 |
N-glycan fucosylation(GO:0036071) |
| 0.0 |
0.2 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.1 |
GO:2000543 |
positive regulation of gastrulation(GO:2000543) |
| 0.0 |
0.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.6 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.2 |
GO:0033135 |
regulation of peptidyl-serine phosphorylation(GO:0033135) |
| 0.0 |
0.1 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.0 |
0.1 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.0 |
0.7 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 |
1.2 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.0 |
0.2 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 |
0.3 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.5 |
GO:0006101 |
citrate metabolic process(GO:0006101) |
| 0.0 |
0.0 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.0 |
1.4 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.0 |
0.3 |
GO:0034311 |
sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
| 0.0 |
0.4 |
GO:0050685 |
positive regulation of mRNA processing(GO:0050685) |
| 0.0 |
0.1 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.0 |
0.4 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.0 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.0 |
0.3 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.0 |
0.2 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.0 |
0.2 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.4 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) |
| 0.0 |
0.3 |
GO:1903672 |
positive regulation of sprouting angiogenesis(GO:1903672) |
| 0.0 |
0.0 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.0 |
0.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.1 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.0 |
1.3 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.1 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.0 |
0.1 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.0 |
0.1 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.0 |
0.0 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.0 |
0.1 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.0 |
0.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.0 |
GO:0051891 |
negative regulation of transforming growth factor beta2 production(GO:0032912) positive regulation of cardioblast differentiation(GO:0051891) |
| 0.0 |
0.3 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.7 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.4 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.0 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.0 |
0.3 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.0 |
0.1 |
GO:0060717 |
chorion development(GO:0060717) |
| 0.0 |
0.5 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.0 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.0 |
0.3 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.0 |
0.0 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.0 |
0.1 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.0 |
0.3 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.0 |
0.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.1 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.0 |
0.1 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.1 |
GO:1903169 |
regulation of calcium ion transmembrane transport(GO:1903169) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.1 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.0 |
0.5 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 |
0.0 |
GO:0090330 |
regulation of platelet aggregation(GO:0090330) |
| 0.0 |
0.2 |
GO:0007631 |
feeding behavior(GO:0007631) |
| 0.0 |
0.2 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.6 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.0 |
0.3 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.0 |
0.2 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) |
| 0.0 |
0.2 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.0 |
0.5 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 |
0.3 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.0 |
0.2 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.1 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.0 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.0 |
0.1 |
GO:0010919 |
regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 |
0.1 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.0 |
0.1 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.0 |
0.1 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.0 |
0.1 |
GO:0044806 |
regulation of growth rate(GO:0040009) G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 |
0.2 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.0 |
0.2 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.0 |
0.1 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.0 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 |
0.0 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
| 0.0 |
0.7 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.0 |
0.3 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
0.1 |
GO:1904816 |
regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.0 |
0.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.0 |
0.8 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.0 |
0.4 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.0 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.0 |
0.1 |
GO:0031100 |
organ regeneration(GO:0031100) |
| 0.0 |
0.0 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.0 |
0.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.0 |
0.1 |
GO:0006424 |
glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.0 |
0.1 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.0 |
0.1 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.0 |
0.1 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.0 |
0.0 |
GO:0097646 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.0 |
0.1 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.0 |
0.1 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.2 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
| 0.0 |
0.8 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.1 |
GO:0071431 |
tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 |
0.2 |
GO:0090224 |
regulation of spindle organization(GO:0090224) |
| 0.0 |
0.1 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 |
0.2 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.0 |
0.1 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.0 |
0.2 |
GO:0051570 |
regulation of histone H3-K9 methylation(GO:0051570) |
| 0.0 |
0.2 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.8 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.1 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.0 |
0.1 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.0 |
0.1 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.0 |
0.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.1 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.0 |
0.0 |
GO:0032079 |
positive regulation of deoxyribonuclease activity(GO:0032077) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.0 |
0.1 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.0 |
0.1 |
GO:0060318 |
regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
| 0.0 |
0.1 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.1 |
GO:0097502 |
mannosylation(GO:0097502) |
| 0.0 |
0.1 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.0 |
0.0 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.0 |
0.2 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.0 |
0.1 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.0 |
0.1 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.0 |
0.3 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 |
0.1 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.0 |
0.0 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.0 |
0.1 |
GO:0019285 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.0 |
0.1 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.3 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.0 |
0.3 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.0 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.0 |
0.1 |
GO:0090194 |
negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
| 0.0 |
0.1 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.0 |
GO:0048557 |
embryonic digestive tract morphogenesis(GO:0048557) |
| 0.0 |
0.3 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.1 |
GO:0061015 |
RNA import into nucleus(GO:0006404) snRNA transport(GO:0051030) snRNA import into nucleus(GO:0061015) |
| 0.0 |
0.7 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 |
0.2 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.0 |
0.6 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.1 |
GO:0051133 |
regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
| 0.0 |
0.0 |
GO:0051209 |
release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) |
| 0.0 |
0.1 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.0 |
0.6 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.1 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
0.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.0 |
0.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.1 |
GO:0006288 |
base-excision repair, DNA ligation(GO:0006288) |
| 0.0 |
0.3 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.2 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.4 |
GO:0036498 |
IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 |
0.1 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.0 |
0.1 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.0 |
0.1 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.0 |
0.1 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.0 |
0.1 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.2 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.0 |
0.1 |
GO:0031638 |
zymogen activation(GO:0031638) |
| 0.0 |
0.1 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.0 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.1 |
GO:0000717 |
nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.0 |
0.0 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.0 |
0.1 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.0 |
0.1 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.0 |
1.8 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
| 0.0 |
0.1 |
GO:0042921 |
glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.0 |
0.1 |
GO:0046719 |
regulation by virus of viral protein levels in host cell(GO:0046719) |
| 0.0 |
0.2 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.0 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.0 |
0.2 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.0 |
0.0 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.0 |
0.1 |
GO:0009698 |
phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
| 0.0 |
0.1 |
GO:0061370 |
testosterone biosynthetic process(GO:0061370) |
| 0.0 |
0.1 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.0 |
0.1 |
GO:0043401 |
hormone-mediated signaling pathway(GO:0009755) steroid hormone mediated signaling pathway(GO:0043401) |
| 0.0 |
0.1 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 |
0.0 |
GO:0008016 |
regulation of heart contraction(GO:0008016) |
| 0.0 |
0.2 |
GO:2000142 |
regulation of DNA-templated transcription, initiation(GO:2000142) |
| 0.0 |
0.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.0 |
0.0 |
GO:0003222 |
ventricular trabecula myocardium morphogenesis(GO:0003222) |
| 0.0 |
0.1 |
GO:0007184 |
SMAD protein import into nucleus(GO:0007184) |
| 0.0 |
0.1 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.4 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.3 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 0.0 |
0.1 |
GO:0046825 |
regulation of protein export from nucleus(GO:0046825) |
| 0.0 |
0.0 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.0 |
0.1 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.0 |
0.0 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
| 0.0 |
0.0 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.0 |
0.1 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 |
0.0 |
GO:0071498 |
response to fluid shear stress(GO:0034405) cellular response to fluid shear stress(GO:0071498) |
| 0.0 |
0.1 |
GO:0000429 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.0 |
0.1 |
GO:0098704 |
fructose import(GO:0032445) cellular response to fructose stimulus(GO:0071332) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.0 |
0.1 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.0 |
0.0 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.0 |
0.1 |
GO:0055119 |
relaxation of cardiac muscle(GO:0055119) |
| 0.0 |
0.3 |
GO:0008334 |
histone mRNA metabolic process(GO:0008334) |
| 0.0 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 |
0.3 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.0 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.0 |
0.1 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.0 |
0.0 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.0 |
0.1 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
0.2 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.0 |
0.1 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.0 |
0.2 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.0 |
0.1 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.0 |
0.3 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.0 |
0.2 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.1 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.0 |
0.0 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.0 |
0.1 |
GO:0015853 |
nucleobase transport(GO:0015851) adenine transport(GO:0015853) |
| 0.0 |
0.2 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
1.0 |
GO:0019079 |
viral genome replication(GO:0019079) |
| 0.0 |
0.5 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.0 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.0 |
0.1 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
1.4 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.0 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.0 |
0.3 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 |
0.1 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.0 |
0.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.1 |
GO:0051145 |
smooth muscle cell differentiation(GO:0051145) |
| 0.0 |
0.7 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.0 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.0 |
0.1 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.0 |
0.2 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.1 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.0 |
0.4 |
GO:0042130 |
negative regulation of T cell proliferation(GO:0042130) |
| 0.0 |
0.1 |
GO:2000329 |
peptidyl-lysine oxidation(GO:0018057) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.0 |
0.0 |
GO:0035987 |
endodermal cell differentiation(GO:0035987) |
| 0.0 |
0.1 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.0 |
0.1 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.0 |
0.1 |
GO:0031179 |
peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.0 |
0.1 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 |
0.3 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.5 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
0.1 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.0 |
0.1 |
GO:1903845 |
negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.0 |
0.2 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.0 |
0.1 |
GO:0048670 |
regulation of collateral sprouting(GO:0048670) |
| 0.0 |
0.0 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 |
0.3 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.1 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.0 |
0.2 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.0 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.0 |
0.1 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.0 |
0.0 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.0 |
0.1 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.0 |
2.5 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
0.0 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.0 |
0.1 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.1 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.4 |
GO:1903959 |
regulation of anion transmembrane transport(GO:1903959) |
| 0.0 |
0.2 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.0 |
0.0 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.0 |
0.0 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.0 |
0.1 |
GO:0042551 |
neuron maturation(GO:0042551) |
| 0.0 |
0.3 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.0 |
GO:0031627 |
telomeric loop formation(GO:0031627) regulation of telomere maintenance via semi-conservative replication(GO:0032213) negative regulation of telomere maintenance via semi-conservative replication(GO:0032214) |
| 0.0 |
0.0 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.0 |
0.0 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.0 |
0.1 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.1 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.0 |
0.0 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
